Skip to main content
[Preprint]. 2023 Feb 16:2023.02.15.528673. [Version 1] doi: 10.1101/2023.02.15.528673

Figure 5:

Figure 5:

Summary of Pharos data by disease cluster. (a) The number of gene targets with a TDL label from Pharos within each cluster and (b) the number of drugs connected to each cluster through gene targets. Drugs were obtained from the Pharos based on their ‘Tclin’ ligand readiness level assignment.